|1.||Teng, Che-Ming: 6 articles (01/2013 - 01/2005)|
|2.||Chen, Chien-Chih: 5 articles (01/2013 - 02/2008)|
|3.||Pan, Shiow-Lin: 4 articles (01/2013 - 02/2008)|
|4.||Chen, Bing-Chang: 2 articles (01/2013 - 02/2008)|
|5.||Lin, Chien-Huang: 2 articles (01/2013 - 02/2008)|
|6.||Hsu, Ming-Jen: 2 articles (01/2013 - 02/2008)|
|7.||Kim, Young Choong: 2 articles (07/2012 - 03/2012)|
|8.||Pai, Hui-Chen: 2 articles (08/2011 - 11/2008)|
|9.||Guh, Jih-Hwa: 2 articles (11/2008 - 01/2005)|
|10.||Wu, Hsing-Yu: 1 article (01/2014)|
03/01/2012 - "The present study aimed to investigate the inhibitory effect of denbinobin on the invasive ability of human cancer cells. "
01/01/2014 - "Denbinobin, a substance extracted from Dendrobium nobile, has anticancer effects in many cancer cell lines. "
01/05/2013 - "Denbinobin, a phenanthraquinone derivative, was shown to exert antitumor activities in several types of cancer cell lines. "
08/01/2011 - "Denbinobin (5-hydroxy-3,7-dimethoxy- 1,4-phenanthraquinone), a biologically active chemical isolated from Ephemerantha lonchophylla, has been demonstrated to display anti-cancer activity. "
08/01/2009 - "There is hope that denbinobin could be developed as an adjuvant in combination therapies aimed at killing cancers that rely on decoy receptors to evade the host's immune surveillance."
|2.||Neoplasm Metastasis (Metastasis)
08/01/2011 - "The denbinobin-treated group showed a significant reduction in tumor metastasis, orthrotopic tumor volume, and spleen enlargement compared to the control group. "
08/01/2011 - "Our findings provide evidences that denbinobin inhibits Src-mediated signaling pathways involved in controlling breast cancer migration and metastasis, suggesting that it has therapeutic potential in breast cancer treatment."
08/01/2011 - "Furthermore, denbinobin inhibited the in vitro migration, invasion and in vivo metastasis of breast cancers in a mouse metastatic model. "
08/01/2011 - "Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways."
08/01/2009 - "Denbinobin and FasL trigger a synergistic cytotoxic effect in human pancreatic adenocarcinoma cells. "
08/01/2009 - "In the present study, we evaluated the anti-cancer activity of a natural compound, denbinobin (5-hydroxy-3,7-dimethoxy-1,4-phenanthraquinone), through decreasing DcR3 levels in human pancreatic adenocarcinoma cell lines. "
08/01/2009 - "Combined treatment with denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC-3 cells."
08/01/2009 - "Recently denbinobin has been shown to diminish the levels of expression of the decoy receptor-3 and also to act synergistically with Fas ligand to induce apoptosis in a pancreatic adenocarcinoma cell line. "
|4.||Stomach Neoplasms (Stomach Cancer)
03/01/2012 - "Taken together, this study demonstrates that denbinobin inhibits invasion and induces apoptosis in highly invasive SNU-484 human gastric cancer cells. "
03/01/2012 - "The present study revealed, for the first time, that denbinobin inhibits the invasive phenotype of SNU-484 human gastric cancer cells in a dose-dependent manner. "
03/01/2012 - "Given that gastric cancer has been estimated to be one of the most common causes of cancer-related death among Asians and the major cause of death from gastric cancer is the metastatic spread of the disease, our findings may provide useful information regarding the application of denbinobin as a chemopreventive agent that could prevent or alleviate metastatic gastric cancer."
03/01/2012 - "Denbinobin, a phenanthrene from dendrobium nobile, inhibits invasion and induces apoptosis in SNU-484 human gastric cancer cells."
|3.||Fas Ligand Protein (Fas Ligand)
|5.||Apoptosis Inducing Factor
|7.||Protein-Tyrosine Kinases (Tyrosine Kinase)
|1.||Heterologous Transplantation (Xenotransplantation)